Evidence map›Paper›PMID 39611209›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Trends in new HIV diagnoses and factors contributing to late diagnosis among migrant populations in EU/EEA countries, 2014 to 2023.

Juliana Reyes-Urueña, Giorgia Stoppa, Federica Pizzolato, Marieke J van der Werf, Charlotte Deogan, Vítor Cabral-Veríssimo, Helena Cortes-Martins, Jessika Deblonde, Asuncion Diaz, Victoria Hernando and 11 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Ending HIV transmission in Europe.The Lancet regional health. Europe · 2026
    Article
  3. Five years to 2030: reaching underserved populations is key to ending the AIDS epidemic in Europe.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Juliana Reyes-UrueñaEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Giorgia StoppaThese authors contributed equally to this work.
Federica PizzolatoThese authors contributed equally to this work.
Marieke J van der WerfEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Charlotte DeoganEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Vítor Cabral-VeríssimoDivision of Epidemiology and Statistics, Directorate-General of Health, Lisbon, Portugal.
Helena Cortes-MartinsDepartment of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Jessika DeblondeEpidemiology of Infectious Diseases, Public Health and Surveillance, Sciensano, Brussels, Belgium.
Asuncion DiazUnidad de Vigilancia de VIH, ITS y Hepatitis B y C, Centro Nacional de Epidemiología, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
Victoria HernandoUnidad de Vigilancia de VIH, ITS y Hepatitis B y C, Centro Nacional de Epidemiología, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
Erna Milunka-KojicDivision of Infectious Diseases, Landspítali Haskolasjúkrahus, Reykjavik, Iceland.
Joël MossongDivision de l'inspection sanitaire, Ministère de la Santé et de la Sécurité Sociale, Luxembourg, Luxembourg.
Kate O'DonnellHealth Protection Surveillance Centre, Dublin, Ireland.
Eline Op de CoulNational Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Chrysa TsiaraHIV/AIDS Surveillance Department, National Public Health Organization, Athens, Greece.
Lilian van LeestUnit for Epidemiological Monitoring, Public Health Agency of Sweden, Stockholm, Sweden.
Dominique Van BeckhovenEpidemiology of Infectious Diseases, Public Health and Surveillance, Sciensano, Brussels, Belgium.
Maria WessmanDepartment of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Robert WhittakerSection for respiratory, blood-borne and sexually transmitted infections, Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
EU/EEA HIV networkThe members of the EU/EEA HIV network are listed under Collaborators.
ECDC/WHO HIV Surveillance Network members

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analysed trends in new HIV diagnoses and factors contributing to late diagnosis among migrants in countries in the European Union (EU)/European Economic Area (EEA) from 2014 to 2023. Of the total reported HIV diagnoses, 45.9% were in migrants, with 13.3% born in EU/EEA countries and 86.7% in non-EU/EEA countries. Late diagnosis was observed in 52.4% of migrants, particularly among non-EU/EEA migrants with heterosexual transmission, regardless of sex. Improved HIV prevention and testing strategies are essential for at-risk migrant populations.

Indexed as

Delayed DiagnosisEuropean UnionHIV InfectionsTransients and MigrantsAdolescentAdultEuropeFemaleHIV TestingHumansMaleMiddle AgedPopulation SurveillanceRisk FactorsYoung AdultDelayed DiagnosisepidemiologyHealthcareHIV infectionsmigrantspopulation surveillance

Identifiers

PMID39611209
PMCPMC11605804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.